
Chronic Lower Back Pain Drugs Market to Hit $4.6B by 2033 Backed by FDA Approvals & Drug Innovation | DataM Intelligence
Chronic Lower Back Pain drugs market surges with demand for non-opioid therapies, aging demographics, & innovative treatments reshaping chronic pain management. AUSTIN, TX, UNITED STATES, June 5, 2025 /EINPresswire.com/ -- The chronic lower …